# Garadacimab (Genetical Recombination) S.C. Injection 200mg Pen (アナエブリ皮下注２００ｍｇペン)

> Prescription product approved in Japan and listed on the NHI drug price list (YJ code 4490411G1020). Nifuji Pharma sources it for licensed healthcare providers, institutions, and distributors; availability, documentation, and export eligibility are confirmed on inquiry.

- **YJ code:** 4490411G1020
- **Product name (Japanese):** アナエブリ皮下注２００ｍｇペン
- **English title:** Garadacimab (Genetical Recombination) S.C. Injection 200mg Pen
- **Active ingredient:** ガラダシマブ（遺伝子組換え）
- **Active ingredient (INN):** Garadacimab (Genetical Recombination)
- **Strength / unit:** ２００ｍｇ１．２ｍＬ１キット
- **Route:** Injection (注射薬)
- **Therapeutic category:** 44 Antiallergic agents (アレルギー用薬) › 449 Other antiallergic agents (その他のアレルギー用薬)
- **Manufacturer:** CSL Behring (ＣＳＬベーリング)
- **NHI price (reference only):** JPY 3037716 per ２００ｍｇ１．２ｍＬ１キット
- **Regulatory status:** Approved in Japan; listed on the NHI drug price list
- **Web page:** https://www.nifujipharma.com/drugs/4490411G1020
- **JSON:** https://www.nifujipharma.com/api/drugs/4490411G1020

## How to request a quotation

Submit the contact form with the product name, quantity, and destination country: https://www.nifujipharma.com/?product=Garadacimab%20(Genetical%20Recombination)%20S.C.%20Injection%20200mg%20Pen%20(%E3%82%A2%E3%83%8A%E3%82%A8%E3%83%96%E3%83%AA%E7%9A%AE%E4%B8%8B%E6%B3%A8%EF%BC%92%EF%BC%90%EF%BC%90%EF%BD%8D%EF%BD%87%E3%83%9A%E3%83%B3)%20%2F%20YJ%204490411G1020#contact

Quotes are for qualified business customers only (licensed healthcare providers, medical institutions, distributors). Payment is by bank transfer in Japanese Yen. Product collection typically takes 2-4 weeks after order confirmation, followed by export procedures and shipping.